Lung Cancer Research Foundation Announces New Research Collaboration with Boehringer Ingelheim
$2.25 Million Research Collaboration Focused on Understanding and Treating Lung Cancers Harboring HER2 Mutations; call for Requests for Proposals NEW...
$2.25 Million Research Collaboration Focused on Understanding and Treating Lung Cancers Harboring HER2 Mutations; call for Requests for Proposals NEW...
Groups partner on research project to test innovative new treatment for KRAS-mutant cancer being developed at Hebrew University NEW YORK,...
Groups Develop Request for Proposals for Research Grants Focused on Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations NEW...